Cargando…

GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis

Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers worldwide. We aimed to identify potential genetic markers that could predict the prognosis of HNSCC. A total of 44 samples of GSE83519 from Gene Expression Omnibus (GEO) datasets and 546 samples of HNSCC from The Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Yue, Zhang, Tiange, Sun, Wei, Liang, Ruobing, Ganesh, Sridha, Chen, Honglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737887/ https://www.ncbi.nlm.nih.gov/pubmed/36499755 http://dx.doi.org/10.3390/ijms232315433

Ejemplares similares

Recent advances of GOLM1 in hepatocellular carcinoma
por: Yan, Jiuliang, et al.
Publicado: (2020)

FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1
por: Zhao, Xinyuan, et al.
Publicado: (2022)

Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
por: Lin, Yan, et al.
Publicado: (2022)

The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy
por: Song, Qi, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer
por: Zeng, Yuyang, et al.
Publicado: (2020)

Structure of CYRI-B (FAM49B), a key regulator of cellular actin assembly
por: Kaplan, Elise, et al.
Publicado: (2020)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation
por: Sun, Zhuolun, et al.
Publicado: (2021)

Identification of key genes for HNSCC from public databases using bioinformatics analysis
por: Ye, Yuchu, et al.
Publicado: (2021)

FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis
por: Chattaragada, M S, et al.
Publicado: (2018)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

GOLM1 suppresses autophagy-mediated anti-tumor immunity in hepatocellular carcinoma
por: Sui, Tianqi, et al.
Publicado: (2021)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma
por: Xu, Feng, et al.
Publicado: (2022)

CYRI/ Fam49 Proteins Represent a New Class of Rac1 Interactors
por: Whitelaw, Jamie A., et al.
Publicado: (2019)

Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018)

GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis
por: Guan, Junhua, et al.
Publicado: (2022)

Review of biomarkers for response to immunotherapy in HNSCC microenvironment
por: Chen, Shaoshi, et al.
Publicado: (2023)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020)

lncRNA in HNSCC: challenges and potential
por: Guglas, Kacper, et al.
Publicado: (2017)

GOLM1 Drives Colorectal Cancer Metastasis by Regulating Myeloid-derived Suppressor Cells
por: Dang, Yunzhi, et al.
Publicado: (2021)

GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth
por: Nagaraj, Meghana, et al.
Publicado: (2022)

Characterization and Functional Study of FAM49B Reveals Its Effect on Cell Proliferation in HEK293T Cells
por: Chen, Yijian, et al.
Publicado: (2022)

Immunohistochemical Evaluation of Adaptor Protein FAM159B Expression in Normal and Neoplastic Human Tissues
por: Beyer, Anna-Sophia Lieselott, et al.
Publicado: (2021)

The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences
por: Hu, Longbo, et al.
Publicado: (2011)

MicroRNA-143 regulates cell migration and invasion by targeting GOLM1 in cervical cancer
por: Zhou, Meiying, et al.
Publicado: (2018)

GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis
por: Pu, Yang, et al.
Publicado: (2021)

FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
por: Guan, Jikui, et al.
Publicado: (2015)

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment
por: Ganesh, Sridha, et al.
Publicado: (2022)

GOLM1 is related to the inflammatory/immune nature of uveal melanoma and acts as a promising indicator for prognosis and immunotherapy response
por: Liang, Xin, et al.
Publicado: (2022)

FAM83A is a potential biomarker for breast cancer initiation
por: Marino, Natascia, et al.
Publicado: (2022)

NR2F6 as a Prognostic Biomarker in HNSCC
por: Klapper, Luise, et al.
Publicado: (2020)

PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT
por: Xu, Ran, et al.
Publicado: (2017)

Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study
por: Beyer, Anna-Sophia Liselott, et al.
Publicado: (2022)

FAM3B Serves as a Biomarker for the Development and Malignancy of Oral Lichen Planus
por: Wang, Wenfang, et al.
Publicado: (2022)

Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation
por: Zhou, Liuqing, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification
por: Lin, Shaochong, et al.
Publicado: (2021)

FAM49B promotes breast cancer proliferation, metastasis, and chemoresistance by stabilizing ELAVL1 protein and regulating downstream Rab10/TLR4 pathway
por: Li, Yanhui, et al.
Publicado: (2021)

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022)

Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
por: Wamsley, Nathan T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a192pauc65g19vajfsju1huhg0